July 31, 2025 · Form 4 insider transaction
Hussain Abbas bought 12,036 shares of NONE, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the "Transaction Agreement"), by and among Mallinckrodt plc (the "Issuer"), Endo, Inc. ("Endo") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary ("Merger Sub"), the Merger Sub merged with and into Endo (the "Business Combination"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer. Upon the reporting person's resignation as a director of the Issuer, effective as of immediately following the Merger Effective Time (as defined in the Transaction Agreement), each restricted unit (the "RSU") held by the reporting person automatically settled in ordinary shares of the Issuer at one share per RSU.